Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-04-29 to 2024-05-20
Current total value of award: $35734.5
Description: 4564464616!NEXPLANON 68 MG IMPLANTS